ANVS
Annovis Bio, Inc.
Company overview
- Market capitalization
- $58.80M
- Employees
- 7
- Latest publication
- 2026-09-29
About Annovis Bio, Inc.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer's disease, as well as in open-label phase 3 to treat parkinson's disease. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia. Annovis Bio, Inc. was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 16,720,362,000USD | 8,750,998USD | 6,291,171USD | 5,161,921USD | 5,011,517USD | 4,998,579USD | 2,689,561USD | 5,785,217USD |
| Selling General Administrative | 1,291,820,000USD | 955,151USD | 1,143,804USD | 1,109,532USD | 1,271,164USD | 1,736,293USD | 1,698,050USD | 1,977,421USD |
| Unclassified Operating Expenses | -17,994,169,818USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 18,012,182USD | 9,706,149USD | 7,434,975USD | 6,271,453USD | 6,282,681USD | 6,734,872USD | 4,387,611USD | 7,762,638USD |
| Operating Income | -18,012,182USD | -9,706,149USD | -7,434,975USD | -6,271,453USD | -6,282,681USD | -6,734,872USD | -4,387,611USD | -7,762,638USD |
| Interest Income | 137,800USD | 167,737USD | 152,317USD | 191,395USD | 187,612USD | 126,273USD | 135,430USD | 25,978USD |
| Net Interest Income | 137,800USD | 167,737USD | 152,317USD | 191,395USD | 187,612USD | 143,212USD | -388,638USD | -1,320,082USD |
| Income Before Tax | -17,606,382USD | -9,834,412USD | -7,262,658USD | -6,220,058USD | -5,537,069USD | -5,864,659USD | -12,638,357USD | -5,020,412USD |
| Net Income | -17,606,382USD | -9,834,412USD | -7,262,658USD | -6,220,058USD | -5,537,069USD | -5,864,659USD | -12,638,357USD | -5,020,412USD |
| Net Income From Continuing Ops | -17,606,382USD | -9,834,412USD | -7,262,658USD | -6,220,058USD | -5,537,069USD | -5,864,659USD | -12,638,357USD | -5,020,412USD |
| Ebitda | -18,012,182USD | -9,706,149USD | -7,434,975USD | -6,271,450USD | -6,282,680USD | -6,734,870USD | -4,387,610USD | -7,762,640USD |
| Total Other Income Expense Net | 405,800USD | -128,263USD | 172,317USD | 51,395USD | 745,612USD | 870,213USD | -8,250,746USD | 2,742,226USD |
| Ebit | — | — | — | -6,271,453USD | -6,282,681USD | -6,734,872USD | -4,387,611USD | -7,762,638USD |
| Depreciation And Amortization | — | — | — | 3USD | 1USD | 2USD | 1USD | -2USD |
| Selling And Marketing Expenses | — | — | — | — | — | 100,000USD | — | — |
| Interest Expense | — | — | — | — | — | 16,939USD | 524,068USD | 1,346,000USD |
| Income Tax Expense | — | — | — | — | — | -5USD | -12,638,357,000USD | 2USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 25,215,607USD | 19,995,447USD | 38,790,603USD | 16,515,543USD | 8,479,031USD | 3,054,025USD | 776,256USD | 111,608USD |
| Selling General Administrative | 4,479,651USD | 6,699,481USD | 6,244,408USD | 8,995,736USD | 6,058,190USD | 3,586,196USD | 829,366USD | 602,329USD |
| Total Operating Expenses | 29,695,258USD | 26,694,928USD | 45,035,000USD | 25,511,279USD | 14,537,221USD | 6,640,221USD | 1,606,000USD | 713,937USD |
| Operating Income | -29,695,258USD | -26,694,928USD | -45,035,000USD | -25,511,279USD | -14,537,221USD | -6,640,221USD | -1,606,000USD | -713,937USD |
| Interest Income | 699,061USD | 331,849USD | 675,921USD | 182,712USD | 13,335USD | 47,225USD | — | — |
| Net Interest Income | 699,061USD | -1,521,340USD | 675,921USD | 182,712USD | 13,335USD | 47,225USD | -40,933USD | 66USD |
| Income Before Tax | -28,854,197USD | -24,590,375USD | -56,204,000USD | -25,328,567USD | -14,487,132USD | -5,462,047USD | -991,000USD | -713,871USD |
| Net Income | -28,854,197USD | -24,590,375USD | -56,204,000USD | -25,145,855USD | -14,487,132USD | -5,462,047USD | -991,000USD | -713,871USD |
| Net Income From Continuing Ops | -28,854,197USD | -24,590,375USD | -41,717,086USD | -25,328,567USD | -14,487,132USD | -5,462,047USD | -990,980USD | -713,871USD |
| Ebitda | -29,695,258USD | -26,694,928USD | -45,035,000USD | -25,511,279USD | -14,500,467USD | -5,456,000USD | -791,000USD | -713,805USD |
| Total Other Income Expense Net | 841,061USD | 2,104,553USD | -11,169,000USD | 182,712USD | 50,089USD | 1,178,174USD | 614,642USD | 66USD |
| Selling And Marketing Expenses | — | 100,000USD | 100,000USD | — | — | — | — | — |
| Interest Expense | — | 1,853,189USD | — | 182,712USD | 13,335USD | 47,225,000USD | 40,933,000USD | 66USD |
| Income Tax Expense | — | -24,565,785,000USD | -45,035USD | -182,712USD | -50,089USD | -1,205,000USD | -694,000USD | -132USD |
| Ebit | — | — | -45,035,011USD | -25,511,279USD | -29,037,000USD | -12,096,000USD | -2,397,000USD | -713,937USD |
| Depreciation And Amortization | — | — | 1USD | 25,511USD | 14,537,000USD | 6,640,221USD | 1,606,000USD | 132USD |
| Non Operating Income Net Other | — | — | — | — | 36,754USD | 1,130,949USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | — | -14,487,132USD | -5,462,047USD | -990,980USD | -713,871USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 22,037,091USD | 16,243,703USD | 21,081,625USD | 17,188,961USD | 21,454,571USD | 26,737,253USD | 13,925,633USD | 14,361,576USD |
| Cash And Equivalents | 18,728,945USD | — | — | — | — | — | — | — |
| Total Liabilities | 26,291,709USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 6,358,709USD | 12,790,645USD | 3,635,375USD | 3,733,797USD | 2,805,124USD | 2,504,366USD | 3,880,987USD | 5,391,376USD |
| Total Stockholder Equity | -4,254,618USD | 3,126,058USD | 16,851,250USD | 13,156,164USD | 18,330,447USD | 24,053,887USD | 9,307,646USD | 7,063,700USD |
| Total Equity Including Noncontrolling Interest | -4,254,618USD | — | — | — | — | — | — | — |
| Accounts Payable | 3,327,138USD | 5,275,668USD | 2,591,000USD | 2,112,026USD | 974,311USD | 1,370,189USD | 2,305,974USD | 4,099,414USD |
| Common Stock | 4,260USD | 2,854USD | 2,719USD | 2,019USD | 1,948USD | 1,948USD | 1,414USD | 1,328USD |
| Retained Earnings | -196,130,856USD | -181,310,041USD | -163,703,659USD | -153,869,247USD | -146,606,000USD | -140,386,000USD | -134,849,462USD | -128,984,000USD |
| Other Current Assets | — | 2,024,622USD | 1,549,287USD | 1,902,562USD | 4,324,285USD | 4,501,078USD | 3,373,717USD | 1,724,946USD |
| Total Liab | — | 13,117,645USD | 4,230,375USD | 4,032,797USD | 3,124,124USD | 2,683,366USD | 4,617,987USD | 7,297,876USD |
| Other Current Liab | — | 7,514,977USD | 1,044,375USD | 1,621,771USD | 1,830,813USD | 1,134,177USD | 1,575,013USD | 1,291,962USD |
| Capital Stock | — | 2,854USD | 2,719USD | 2,019USD | 1,948USD | 1,948USD | 1,414USD | 1,328USD |
| Other Assets | — | 2,024,622,000USD | — | — | 4,324,285,000USD | 4,501,078,000USD | — | 1,724,946,000USD |
| Cash | — | 14,219,081USD | 19,532,338USD | 15,286,399USD | 17,130,286USD | 22,236,175USD | 10,551,916USD | 12,636,630USD |
| Cash And Short Term Investments | — | 14,219,081USD | 19,532,338USD | 15,286,399USD | 17,130,286USD | 22,236,175USD | 10,551,916USD | 12,636,630USD |
| Total Current Assets | — | 16,243,703USD | 21,081,625USD | 17,188,961USD | 21,454,571USD | 26,737,253USD | 13,925,633USD | 14,361,576USD |
| Net Debt | — | -14,219,081USD | -19,532,338USD | -15,286,399USD | -17,130,286USD | -22,236,175USD | -10,551,916USD | -12,636,630USD |
| Common Stock Shares Outstanding | — | 27,848,000shares | 24,812,596shares | 19,685,071shares | 19,486,231shares | 12,235,000shares | 13,795,000shares | 12,976,000shares |
| Non Current Assets Total | — | 0USD | 1,549,287,000USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Non Current Liabilities Total | — | 326,999USD | 595,000USD | 299,000USD | 319,000USD | 179,000USD | 737,000USD | 1,906,500USD |
| Net Working Capital | — | 3,453,058USD | 17,446,250USD | 13,455,164USD | 18,649,447USD | 24,232,887USD | 10,044,646USD | 8,970,200USD |
| Unclassified Non Current Assets | — | -2,024,622,000USD | — | — | -4,324,285,000USD | -4,501,078,000USD | — | -1,724,946,000USD |
| Unclassified Equity | — | 184,430,391USD | 180,549,471USD | 167,021,373USD | 164,932,551USD | 164,435,991USD | 144,154,280USD | 136,045,044USD |
| Non Currrent Assets Other | — | — | 1,549,287,000USD | — | — | — | — | — |
| Short Term Investments | — | — | — | — | — | — | — | 12,623,993,370USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | -12,623,993,370USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | — | 1,906,500USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 21,081,625USD | 13,925,633USD | 10,208,264USD | 36,022,069USD | 46,001,478USD | 8,119,334USD | 1,117,107USD | 50,992USD |
| Other Current Assets | 1,549,287USD | 3,373,717USD | 4,453,544USD | 7,644,376USD | 315,464USD | 44,676USD | 745,654,000USD | 11,880USD |
| Total Liab | 4,230,375USD | 4,617,987USD | 17,959,110USD | 7,698,539USD | 1,506,514USD | 578,380USD | 9,693,507USD | 7,644,895USD |
| Total Stockholder Equity | 16,851,250USD | 9,307,646USD | -7,750,846USD | 28,323,530USD | 44,494,964USD | 7,540,954USD | -8,576,400USD | -7,593,903USD |
| Other Current Liab | 1,044,375USD | 1,575,013USD | 2,986,273USD | 3,737,285USD | 818,440USD | 236,524USD | 776,871USD | 499,518USD |
| Common Stock | 2,719USD | 1,414USD | 1,052USD | 816USD | 810USD | 689USD | 28USD | 28USD |
| Capital Stock | 2,719USD | 1,414USD | 1,052USD | 816USD | 810USD | 689USD | 28USD | 28USD |
| Retained Earnings | -163,703,659USD | -134,849,462USD | -110,259,087USD | -54,054,774USD | -28,726,207USD | -14,239,075USD | -8,777,028USD | -7,786,048USD |
| Other Assets | 1,549,287,000USD | 3,373,717,000USD | — | — | — | — | 369,595USD | — |
| Cash | 19,532,338USD | 10,551,916USD | 5,754,720USD | 28,377,693USD | 45,686,014USD | 8,074,658USD | 1,858USD | 35,312USD |
| Cash And Short Term Investments | 19,532,338USD | 10,551,916USD | 5,754,720USD | 28,377,693USD | 45,686,014USD | 8,074,658USD | 1,858USD | 35,312USD |
| Total Current Assets | 21,081,625USD | 13,925,633USD | 10,208,264USD | 36,022,069USD | 46,001,478USD | 8,119,334USD | 747,512USD | 50,992USD |
| Total Current Liabilities | 3,635,375USD | 3,880,987USD | 4,279,110USD | 7,698,539USD | 1,506,514USD | 578,380USD | 2,010,748USD | 567,943USD |
| Net Debt | -19,532,338USD | -10,551,916USD | -5,754,720USD | -28,377,693USD | -45,686,014USD | -8,074,658USD | 497,949USD | -35,312USD |
| Accounts Payable | 2,591,000USD | 2,305,974USD | 1,292,837USD | 3,961,254USD | 688,074USD | 341,856USD | 1,233,877USD | 68,425USD |
| Common Stock Shares Outstanding | 20,552,000shares | 12,235,000shares | 9,023,000shares | 8,162,000shares | 7,626,000shares | 6,309,000shares | 6,845,000shares | 4,400,000shares |
| Non Current Assets Total | 1,549,287,000USD | 13,911,707,367USD | 0USD | 0USD | 0USD | 0USD | 369,595USD | 0USD |
| Non Current Liabilities Total | 595,000USD | 737,000USD | 13,680,000USD | 3,961,254USD | 688,074USD | 341,856USD | 7,682,759USD | 7,076,952USD |
| Non Currrent Assets Other | 1,549,287,000USD | — | — | — | — | — | 369,595USD | 0USD |
| Net Working Capital | 17,446,250USD | 10,044,646USD | 5,929,154USD | 28,323,530USD | 44,494,964USD | 7,540,954USD | -1,263,236USD | -516,951USD |
| Unclassified Non Current Assets | -1,549,287,000USD | 10,537,990,367USD | — | — | — | — | — | — |
| Unclassified Equity | 180,549,471USD | 144,154,280USD | 102,506,137USD | 82,376,672USD | 73,219,551USD | 21,778,651USD | 7,277,524USD | 7,269,041USD |
| Short Term Investments | — | 10,541,364,084USD | — | — | — | — | — | — |
| Unclassified Current Assets | — | -10,541,364,084USD | — | — | — | — | -745,643,421USD | — |
| Unclassified Non Current Liabilities | — | — | 13,680,000USD | 3,961,254USD | — | — | 6,707,357USD | 7,076,952USD |
| Accumulated Other Comprehensive Income | — | — | — | 0USD | 0USD | 0USD | -7,076,952USD | -7,076,952USD |
| Net Tangible Assets | — | — | — | — | 44,494,964USD | 7,540,954USD | -8,576,400USD | -7,593,903USD |
| Deferred Long Term Liab | — | — | — | — | — | — | 369,595USD | — |
| Other Liab | — | — | — | — | — | — | 106,000USD | — |
| Short Long Term Debt Total | — | — | — | — | — | — | 499,807USD | — |
| Long Term Debt | — | — | — | — | — | — | 499,807USD | — |
| Net Receivables | — | — | — | — | — | — | 735,075USD | — |
| Inventory | — | — | — | — | — | — | -745,643,421USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Stock Based Compensation | 1,791,478USD |
| Change To Liabilities | 2,723,335USD |
| Change In Working Capital | -1,022,237USD |
| Operating Cash Flow | -30,925,244USD |
| Financing Cash Flow | 30,121,851USD |
| Change In Cash | -803,393USD |
| End Cash Flow | 18,728,945USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -17,606,382,000USD | -9,834,412USD | -7,262,658USD | -6,220,058USD | -5,537,069USD | -5,864,659USD | -12,638,357USD | -5,020,412USD |
| Stock Based Compensation | 182,823,000USD | 356,524USD | 444,647USD | 496,618USD | 499,887USD | 1,482,413USD | 393,080USD | 1,596,512USD |
| Other Non Cash Items | 8,403,255,065USD | 296,000USD | -20,000USD | 140,000USD | -558,000USD | -743,941USD | 8,386,177USD | -2,766,248USD |
| Change In Working Capital | 8,679,935USD | 254,853USD | 3,350,396USD | 477,551USD | -2,503,982USD | -3,159,159USD | 657,779USD | 2,814,963USD |
| Total Cash From Operating Activities | -9,011,624,000USD | -8,927,035USD | -3,487,615USD | -5,105,889USD | -8,099,164USD | -8,285,346USD | -3,201,321USD | -3,375,185USD |
| Capital Expenditures | 0USD | 0USD | -5USD | 0USD | -4USD | -4USD | 0USD | -5USD |
| Free Cash Flow | -9,011,624,000USD | -8,927,035USD | -3,487,620USD | -5,105,889USD | -8,099,164USD | -8,285,346USD | -3,201,321USD | -3,375,185USD |
| Total Cash From Financing Activities | 3,698,367,000USD | 13,172,974USD | 1,643,728USD | 0USD | 19,783,423USD | 6,200,632USD | 11,840,184USD | 4,235,984USD |
| Issuance Of Capital Stock | 3,698,367USD | 13,170,975USD | 1,643,728USD | 0USD | 19,783,423USD | 6,200,632USD | 4,355,181USD | 4,235,984USD |
| Change In Cash | -5,313,257,000USD | 4,245,939USD | -1,843,887USD | -5,105,889USD | 11,684,259USD | -2,084,714USD | 8,638,863USD | 860,799USD |
| Begin Period Cash Flow | 19,532,338,000USD | 15,286,399USD | 17,130,286USD | 22,236,175USD | 10,551,916USD | 12,636,630USD | 3,997,767USD | 3,136,968USD |
| End Period Cash Flow | 14,219,081,000USD | 19,532,338USD | 15,286,399USD | 17,130,286USD | 22,236,175USD | 10,551,916USD | 12,636,630USD | 3,997,767USD |
| Other Cashflows From Financing Activities | 3,694,668,633USD | -6,590,665,577USD | — | — | — | 8,016,978,181USD | 7,485,003USD | 4,235,984USD |
| Unclassified Financing Cash Flow | — | 6,590,667,576USD | — | — | — | -8,016,978,181USD | — | -4,235,984USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -28,854,197,000USD | -24,590,375,000USD | -56,204,313USD | -25,328,567USD | -14,487,132USD | -5,462,047USD | -990,980USD | -713,871USD |
| Stock Based Compensation | 1,797,676,000USD | 3,836,770,000USD | 4,628,406USD | 9,152,520USD | 4,697,627USD | 1,864,913USD | 8,483USD | 82,728USD |
| Other Non Cash Items | 1,435,239,182USD | -1,141,680,705USD | 11,837,200USD | 5,879,340USD | 4,351,409USD | 27,025USD | 84,429USD | 85,410USD |
| Change In Working Capital | 1,578,818USD | 681,705USD | -228,597USD | -1,136,887USD | 657,346USD | -400,714USD | 421,526USD | 72,534USD |
| Total Cash From Operating Activities | -25,619,703,000USD | -21,894,604,000USD | -39,967,304USD | -17,312,934USD | -9,132,159USD | -3,970,823USD | -476,542USD | -558,609USD |
| Capital Expenditures | 0USD | -4USD | -4USD | -4USD | 0USD | -3USD | 0USD | 0USD |
| Free Cash Flow | -25,619,703,000USD | -21,894,604,000USD | -39,967,304USD | -17,312,934USD | -9,132,159USD | -3,970,820USD | -476,542USD | -558,609USD |
| Total Cash From Financing Activities | 34,600,125,000USD | 26,691,800,000USD | 17,344,331USD | 4,613USD | 46,743,515USD | 12,043,623USD | 443,088USD | 246,449USD |
| Issuance Of Capital Stock | 34,598,126USD | 18,666,797USD | 8,571,191USD | 8,571,191USD | 46,648,413USD | 12,034,406USD | 12,084,406USD | 246,449USD |
| Change In Cash | 8,980,422,000USD | 4,797,196,000USD | -22,622,973USD | -17,308,321USD | 37,611,356USD | 8,072,799USD | -33,454USD | -312,160USD |
| Begin Period Cash Flow | 10,551,916,000USD | 5,754,720,000USD | 28,377,693USD | 45,686,014USD | 8,074,658USD | 1,858USD | 35,312USD | 347,472USD |
| End Period Cash Flow | 19,532,338,000USD | 10,551,916,000USD | 5,754,720USD | 28,377,693USD | 45,686,014USD | 8,074,657USD | 1,858USD | 35,312USD |
| Other Cashflows From Financing Activities | 34,565,524,875USD | 26,673,133,203USD | 458,385USD | 4,613USD | 95,102USD | -12,025,189USD | -86,912USD | 490,098USD |
| Unclassified Financing Cash Flow | — | — | 8,314,755USD | -8,571,191USD | — | 12,025,189USD | -12,084,406USD | -1,020,099USD |
| Unclassified Operating Cash Flow | — | — | — | -5,879,340USD | -4,351,409USD | — | -1,191,000USD | — |
| Change To Liabilities | — | — | — | — | 928,134USD | -1,101,692USD | 969,091USD | -2,682USD |
| Sale Purchase Of Stock | — | — | — | — | 46,743,515USD | 12,043,623USD | — | 246,450USD |
| Cash And Cash Equivalents Changes | — | — | — | — | 37,611,356USD | 8,072,800USD | — | — |
| Depreciation | — | — | — | — | — | 129,000USD | 1,191,000USD | — |
| Change To Account Receivables | — | — | — | — | — | 735,075USD | -735,075USD | — |
| Change To Inventory | — | — | — | — | — | -735,075USD | 735,075USD | — |
| Net Borrowings | — | — | — | — | — | — | 530,000USD | 530,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.